The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

Elevated PSA Hyperlink to Increased Recurrence Danger in Intermediate-Danger Prostate Most cancers

Excessive pre-HIFU PSA ranges in intermediate-risk prostate most cancers have been linked to elevated recurrence and remedy failure, per ASCO 2025 analysis.Amongst sufferers...

Breaking Down the Implications of Calquence Mixture Remedy in MCL

The remedy mixture of Calquence (acalabrutinib) plus bendamustine and Rituxan (rituximab) was just lately granted full approval by the Meals and Drug Administration (FDA)...

Jim and Melanie’s Affected person-Caregiver Story

Sue McCarthy acquired diagnoses of breast most cancers in 2001 and lung most cancers in 2018. Make amends for all of Sue's blogs right...

Breyanzi Improves Responses in R/R Indolent B-Cell Non-Hodgkin Lymphoma

Breyanzi confirmed important efficacy and sturdy responses in adults with relapsed or refractory marginal zone lymphoma within the section 2 TRANSCEND FL trial.Amongst...

Talzenna Plus Xtandi Could Enhance Survival in mCRPC

Talzenna plus Xtandi improved total survival in HRR-deficient mCRPC by 14 months and lowered demise danger by 38%, per TALAPRO-2 trial information.Amongst sufferers...

Hot Topics